Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Peripheral Blood Stem Cell Transplantation for Relapsed AIDS-Related Lymphoma
NCT00005824Phase 2Completed
- Sponsor
- AIDS Malignancy Consortium
- Start
- Nov 2000
- Primary completion
- Jul 2004
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous peripheral blood stem cell transplantation in AIDS-related lymphoma, sponsored by AIDS Malignancy Consortium. Primary endpoint: Safety and Tolerability up to 3 years. Started Nov 2000; status: completed.
02
Drugs
autologous peripheral blood stem cell transplantation
03
Conditions
AIDS-related lymphoma
Beyond the preview
Go deeper on NCT00005824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005824.